• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Derma Sciences sales jump 16 percent | Earnings roundup

Derma Sciences sales jump 16 percent | Earnings roundup

March 31, 2011 By MassDevice staff

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Derma Sciences sales jump 16 percent
Derma Sciences Inc. (NSDQ:DSCI) reported losses of $347,198, or 5 cents per diluted share, on sales of $15.3 million during the three months ended Dec. 31, 2010. That compares with profits $843, or less than 1 cent per diluted share, on sales of $13.6 million during the same period in 2009.

Full-year losses were $2.4 million, or 39 cents per share, on sales of $56.5 million. That compares with losses of $1.3 million, or 25 cents per share, on sales of $48.5 million in 2009.
Read more

Bacterin losses widen more than 340 percent
Bacterin International Holdings Inc. (NYSE Amex:BONE) reported losses of $5.5 million, or 15 cents per basic share, on sales of $5.3 million during the three months ended Dec. 31, 2010. That compares with losses of $1.6 million, or 6 cents per basic share, on sales of $2.2 million during the same period in 2009.

Full-year losses were $18.2 million, or 57 cents per share, on sales of $15.4 million. That compares with losses of $4.1 million, or 16 cents per share, on sales of $7.4 million in 2009.
Read more

Response Genetics losses halve
Response Genetics Inc. (NSDQ:RGDX) reported losses of $1.1 million, or 6 cents per basic share, on sales of $6.4 million during the three months ended Dec. 31. That compares with losses of $1.7 million, or 11 cents per diluted share, on sales of $3.4 during the same period in 2009.

Full-year losses were $4.7 million, or 26 cents per share, on sales of $21.3 million. That compares with losses of $9.3 million, or 70 cents per share, on sales of $9.1 million in 2009.
Read more

Nephros losses remain unchanged after small sales bump
Nephros Inc. (OTC:NEPHD) reported losses of $665,000, or 32 cents per diluted share, on sales of $517,000 during the three months ended Dec. 31, 2010. That compares with losses of $483,000, or 25 cents per diluted share, on sales of $792,000 during the same period in 2009.

Full-year losses were $1.9 million, or 93 cents per share, on sales of $2.9 million. That compares with losses of $2.0 million, or $1.06 per share, on sales of $2.7 million in 2009.
Read more

Guided Therapeutics losses ease after sales double
Guided Therapeutics Inc. (OTC:GTHP) reported losses of $280,000, or 1 cent per diluted share, on sales of $1.1 million during the three months ended Dec. 31, 2010. That compares with losses of $1.5 million, or 8 cents per diluted share, on sales of $550,000 during the same period in 2009.

Full-year losses were $4.5 million, or 12 cents per share, on sales of $3.4 million. That compares with losses of $6.4 million, or 38 cents per share, on sales of $1.6 million in 2009.
Read more

Elbit sales push company into the black
Elbit Imaging Ltd. (NSDQ:EMITF) reported profits of $19.5 million on sales of $111.9 million during the year ended Dec. 31, 2010. That compares with losses of $190.6 million on no revenue in 2009.
Read more

Spherix losses ease despite unchanged sales
Spherix Inc. (NSDQ:SPEX) reported losses of $7.7 million, or 43 cents per diluted share, on sales of $1.4 million during the year ended Dec. 31, 2010. That compares with losses of $9.1 million, or 62 cents per diluted share, on sales of $1.4 million in 2009.
Read more

NeurogesX losses double
NeurogesX Inc. (NSDQ:NGSX) reported losses of $12.4 million, or 69 cents per diluted share, on sales of $458,000 during the three months ended Dec. 31, 2010. That compares with losses $5.1 million, or 29 cents per diluted share, on no revenues during the same period in 2009.

Full-year losses were $44.5 million, or $2.51 cents per share, on sales of $688,000. That compares with losses of $21.9 million, or $1.24 per share, on no revenues in 2009.
Read more

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: Bacterin International Holdings Inc., Derma Sciences Inc., Elbit Imaging Ltd., Guided Therapeutics Inc., Nephros, NeurogesX Inc., Q4, Response Genetics Inc., Spherix Inc.

In case you missed it

  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy
  • NuVasive chief commercial officer Massimo Calafiore is stepping down

RSS From Medical Design & Outsourcing

  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy